Santa Clara, CA, United States of America

Pavel V Bondarenko

USPTO Granted Patents = 11 


Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Santa Clara, CA (US) (2004)
  • Thousand Oaks, CA (US) (2004 - 2024)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pavel V Bondarenko

Introduction

Pavel V Bondarenko is a prominent inventor based in Santa Clara, CA. He has made significant contributions to the field of metabolic disorder treatments, holding a total of 11 patents. His work focuses on innovative methods that address various metabolic diseases, including type 2 diabetes and obesity.

Latest Patents

Among his latest patents is a method for treating or ameliorating metabolic disorders using binding proteins for the gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists. This invention provides methods for treating metabolic diseases and disorders by utilizing an antigen binding protein specific for the GIPR polypeptide. The metabolic diseases targeted include type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy. In certain embodiments, the antigen binding protein is administered alongside a GLP-1 receptor agonist. Another notable patent involves low-viscosity antigen binding proteins and methods for their preparation. This invention focuses on creating antigen binding proteins specific for PCSK9 with reduced viscosity by substituting residues in high viscosity variable domain subfamilies with those in correlating low viscosity subfamilies.

Career Highlights

Pavel has worked with notable companies such as Amgen Inc. and Thermo Finnigan LLC. His experience in these organizations has contributed to his expertise in the field of biopharmaceuticals and metabolic disorder treatments.

Collaborations

Throughout his career, Pavel has collaborated with esteemed colleagues, including Douglas Rehder and Thomas M Dillon. These partnerships have further enhanced his innovative work and contributions to the industry.

Conclusion

Pavel V Bondarenko's innovative work in the treatment of metabolic disorders showcases his dedication to advancing medical science. His numerous patents reflect his commitment to finding effective solutions for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…